Post-menopausal patients have many options and choices for hormone therapy. But what are the issues and increased risks, if any? What are the latest updates from recent hormone therapy clinical trials and how does this impact clinical practice? Host Dr. Prathima Setty welcomes Dr. JoAnn V. Pinkerton to discuss various hormone therapy options and the latest updates in this area of concern for our patients.
Dr. Pinkerton is the Director for the Midlife Division and the Midlife Health Center, a nationally recognized multidisciplinary center for women's midlife health. She serves as a member of the Board of Trustees for the North American Menopause Society and the Board of Directors for the National Women's Health Resource Center.
The interview was conducted live at The North American Menopause Society (NAMS) 2014 meeting. Founded in 1989, NAMS is North America's leading nonprofit organization dedicated to promoting the health and quality of life of all women during midlife and beyond through an understanding of menopause and healthy aging. Its multidisciplinary membership of 2,000 leaders in the field-including clinical and basic science experts from medicine, nursing, sociology, psychology, nutrition, anthropology, epidemiology, pharmacy, and education-makes NAMS uniquely qualified to serve as the definitive resource for health professionals and the public for accurate, unbiased information about menopause and healthy aging. To learn more about NAMS, visit www.menopause.org.